Mylan, U.S. finalize $465 million EpiPen settlement

BOSTON (Reuters) - Mylan NV has finalized a $465 million settlement with the U.S. Justice Department resolving claims it overcharged the government for its EpiPen emergency allergy treatment, which became the center of a firestorm over price increases.